New research discovers key to survival of brain cells

Nicolas G. Bazan, MD, Ph.D, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, and David Stark, an MD/Ph.D student working in his lab, have discovered how a key chemical neurotransmitter that interacts with two receptors in the brain promotes either normal function or a disease process -- determining whether brain cells live or die. The work is published and highlighted in the September 28, 2011 issue of the Journal of Neuroscience.

These findings reveal how receptor signaling takes place between receptors of synapses (gaps between neurons through which chemical or pass permitting cells to "talk" to each other) and the mechanisms involved in initiating disease. The receptors, called NMDARs, are located both inside and outside of the synapses. Activation of the NMDRs inside (synaptic) allows the synapse to adjust response to signals and activation of the synaptic NMDRs is also required for survival of the cell. In contrast, activation of the receptors outside the synapse (extrasynaptic) leads to cell death.

The LSUHSC research team believed that activation of the extrasynaptic NMDRs promotes the pathological effects of 2 (COX-2), a protein known to contribute to inflammation associated with . They found that activating the synaptic NMDRs greatly increased levels of COX-2, but not of the chemical (arachidonic acid) upon which COX-2 acts. Conversely, activating the extrasynaptic NMDRs increased the levels of arachidonic acid, but not COX-2. The researchers discovered, however, when synaptic and extrasynaptic NMDARs were sequentially activated, the levels of both COX-2 and arachidonic acid increased, as did neurotoxic inflammation.

"We have discovered a fascinating relationship regarding the "conversations" that occur between these two in the brain," said Dr. Nicolas G. Bazan, Professor and Director, LSUHSC Neuroscience Center of Excellence.

"In this paper, we demonstrate how these signals affect cell functions and how they lead to diseases, including stroke, epilepsy and other neurodegenerative disorders. Targeting mechanisms that couple sequential synaptic then extrasynaptic NMDAR stimulations may lead to new anti-inflammatory/neuroprotective approaches."

The research was supported by grants from the National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Center for Research Resources, and the National Center for Complementary and Alternative Medicine.

"I have a very gifted and talented young MD/Ph.D student in my lab, David Stark, who has a National Institutes of Health award, performed exemplary experiments and co-authored the paper with me," said Dr. Bazan.

Provided by Louisiana State University Health Sciences Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Fish oil protects against diseases like Parkinson's, study

Apr 19, 2009

Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present ...

Study puts a new spin on ibuprofen's actions

Sep 25, 2011

Ibuprofen, naproxen, and related non-steroidal anti-inflammatory drugs (NSAIDs) – the subjects of years of study – still have some secrets to reveal about how they work.

Recommended for you

Optogenetics has 'completely changed neuroscience'

12 hours ago

It's getting harder to find the line between science and science fiction. One of the hot research techniques these days, "optogenetics," uses gene therapy to deliver light-sensitive proteins to specific cells. Then researchers ...

User comments